← Leaderboards
Blake M Paterson
Alba Therapeutics Corporation
$411,550
Attributed
$557,788
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $292.5K · FY2006–11$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$557,788 · 2
By mechanism
R43$292,476 · 1
R41$265,312 · 1
Top collaborators
- Brendan J Canning1 shared
Others in their field
Top investigators on “Acute”
- Barton F Haynes · Duke University$295,684,085
- Peter C Adamson · National Childhood Cancer Foundation$256,842,224
- Judith S. Currier · University Of California Los Angeles$242,306,415
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$230,305,108
- Lawrence Corey · Fred Hutchinson Cancer Center$204,110,869
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
Research focus
AcuteAdverse EffectsAmbroxolAnimal ModelAnimalsAntitussive AgentsAsthmaBaseBioavailableBiological AvailabilityBiological ProductsBooksBradykininBusinessesCapitalCapsaicinCaringCaviaChronicCitric AcidClinicClinical ResearchCodeineAcids